Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Analyzing Stability Data for Gel Formulations – V 2.0

Posted on By

Gel Manufacturing: SOP for Analyzing Stability Data for Gel Formulations – V 2.0

Standard Operating Procedure for Analyzing Stability Data of Gel Formulations


Department Gel Manufacturing
SOP No. SOP/GM/105/2025
Supersedes SOP/GM/105/2022
Page No. Page 1 of 10
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2027

1. Purpose

To provide a standardized method for compiling, reviewing, analyzing, and interpreting stability data of gel formulations, to determine product shelf life and ensure regulatory compliance.

2. Scope

This procedure applies to all gel-based pharmaceutical products undergoing real-time or accelerated stability studies in the Gel

Manufacturing and Quality Control departments.

3. Responsibilities

  • Stability Coordinator: Compiles, verifies, and manages stability data.
  • QC Analyst: Performs stability testing as per the approved protocol and records data.
  • QA Officer: Reviews stability data for compliance with specifications and regulatory filing.

4. Accountability

The Head – Quality Assurance is accountable for the final approval of stability data analysis reports and ensuring adherence to regulatory requirements.

See also  Gel Manufacturing: SOP for Cleaning of Gel Transfer Vessels - V 2.0

5. Procedure

5.1 Data Compilation

  1. Stability test data (physical, chemical, and microbiological) should be recorded at each time point (0, 1, 3, 6, 9, 12, 18, and 24 months for long-term; 0, 1, 2, 3, and 6 months for accelerated).
  2. Data shall be captured in a tabular format using the “Stability Data Compilation Sheet” (Annexure-1).
  3. Ensure all data is transcribed directly from raw data sheets or instrument printouts without alteration.

5.2 Data Validation

  1. Check for any transcription errors, missing entries, unit inconsistencies, or deviations from specifications.
  2. Investigate any out-of-trend (OOT) or out-of-specification (OOS) results through QA deviation handling procedures.

5.3 Trend Analysis

  1. Plot stability-indicating parameters such as assay, pH, viscosity, microbial load, and appearance over time.
  2. Use statistical tools such as regression analysis or ANOVA to identify trends and predict shelf-life degradation patterns.
  3. Interpret the data to assess whether there is any significant change in quality attributes over time.
See also  Untitled

5.4 Shelf-Life Determination

  1. Use ICH Q1E guidelines to apply statistical approaches for estimating shelf-life.
  2. If no significant changes are observed during the stability period, use the last compliant time point as a reference for assigning shelf life.
  3. Document the rationale for shelf-life determination in the final report.

5.5 Report Generation

  1. Compile findings into a “Stability Data Analysis Report” (Annexure-2), which should include summary tables, trend charts, interpretations, and conclusions.
  2. The report should be signed by the Stability Coordinator, reviewed by QC Manager, and approved by QA Head.

5.6 Regulatory Compliance

  1. Ensure that data presentation aligns with regulatory submission formats (e.g., CTD format).
  2. Store all analytical data and summary reports in the stability archive system for future inspection and audit readiness.

6. Abbreviations

  • OOT: Out-of-Trend
  • OOS: Out-of-Specification
  • CTD: Common Technical Document
  • QA: Quality Assurance
  • QC: Quality Control
  • SOP: Standard Operating Procedure

7. Documents

  1. Stability Data Compilation Sheet – Annexure-1
  2. Stability Data Analysis Report – Annexure-2
  3. Stability Protocol
  4. Stability Summary for Regulatory Submission
See also  Gel Manufacturing: SOP for Primary Packaging of Gels - V 2.0

8. References

  • ICH Q1E: Evaluation for Stability Data
  • ICH Q1A(R2): Stability Testing of New Drug Substances and Products
  • Schedule M – Stability Testing Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Stability Data Compilation Sheet


Time Point Assay (%) pH Viscosity (cP) Appearance Microbial Count (cfu/g) Remarks
0 Month
1 Month
3 Month

Annexure-2: Stability Data Analysis Report

Batch No.
Product Name
Storage Condition
Study Type (Accelerated / Real-time)
Shelf-life Conclusion
Summary of Findings
Prepared By
Reviewed By
Approved By

Revision History

Revision Date Revision No. Change Description Reason Approved By
01/06/2022 1.0 Initial release New SOP QA Head
02/06/2025 2.0 Included updated ICH references and annexures Annual Review QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Conducting Quality Audits in Injectable Manufacturing – V 2.0
Next Post: Creams: SOP for Managing Out-of-Trend (OOT) Results – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version